Anti-EGFR antibody-drug conjugate for triple-negative breast cancer therapy.

Si, Yingnan; Xu, Yuanxin; Guan, JiaShiung; Chen, Kai; Kim, Seulhee; Yang, Eddy S; Zhou, Lufang; Liu, Xiaoguang Margaret

Si, Yingnan; Xu, Yuanxin; Guan, JiaShiung; Chen, Kai; Kim, Seulhee; Yang, Eddy S; Zhou, Lufang; Liu, Xiaoguang Margaret.

Afiliação

Si Y; Department of Biomedical Engineering University of Alabama at Birmingham (UAB) Birmingham AL USA.
Xu Y; Department of Biomedical Engineering University of Alabama at Birmingham (UAB) Birmingham AL USA.
Guan J; Department of Medicine UAB Birmingham AL USA.
Chen K; Department of Medicine UAB Birmingham AL USA.
Kim S; Department of Biomedical Engineering University of Alabama at Birmingham (UAB) Birmingham AL USA.
Yang ES; Department of Radiation Oncology O'Neal Comprehensive Cancer Center at UAB Birmingham AL USA.
Zhou L; Department of Medicine UAB Birmingham AL USA.
Liu XM; Department of Biomedical Engineering University of Alabama at Birmingham (UAB) Birmingham AL USA.

Eng Life Sci ; 21(1-2): 37-44, 2021 Jan.

Article em En | MEDLINE | ID: mdl-33531889

Palavras-chave

antibodydrug conjugate; epidermal growth factor receptor; targeted therapy; triplenegative breast cancer

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Eng Life Sci Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google